Free Trial

Trinity Biotech (TRIB) Earnings Date, Estimates & Call Transcripts

Trinity Biotech logo
$1.61 -0.02 (-1.23%)
(As of 11/12/2024 ET)

Trinity Biotech Latest Earnings Summary

Upcoming Q3
Earnings Date
Jan. 29Estimated
Actual EPS
(Aug. 14)
-$0.55 Beat By $0.10
Consensus EPS
(Aug. 14)
-$0.65

Trinity Biotech posted Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.55, which beat analysts' consensus estimates of -$0.65 by $0.10. Quarterly revenue was reported to be $15.84 million, above analyst estimates of $15.75 million. With a trailing EPS of -$2.70, Trinity Biotech's earnings are expected to grow next year, from ($1.91) to ($1.03) per share.

TRIB Upcoming Earnings

Trinity Biotech's next earnings date is estimated for Wednesday, January 29, 2025, based off prior year's reporting schedules.

Get Trinity Biotech Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Trinity Biotech and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TRIB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TRIB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Trinity Biotech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20241-$0.65-$0.65-$0.65
Q3 20241-$0.54-$0.54-$0.54
Q4 20241-$0.47-$0.47-$0.47
20243-$1.66-$1.66-$1.66
Q1 20251-$0.35-$0.35-$0.35
Q2 20251-$0.31-$0.31-$0.31
Q3 20251-$0.21-$0.21-$0.21
Q4 20251-$0.17-$0.17-$0.17
FY 20254($1.04)($1.04)($1.04)

Trinity Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
1/29/2025
(Estimated)
------- 
8/14/2024Q2 2024-$0.65-$0.55+$0.10-$0.39$15.75M$15.84M
5/23/2024Q1 2024--$0.37 -$0.37-$0.37-$14.70M
4/4/2024Q4 2023--$0.68 -$0.68-$0.64-$13.43M
1/31/2024Q3 2023--$0.90 -$0.90-$0.18-$14.68M
10/3/2023Q2 2023--$1.00 -$1.00-$0.24-$13.90M  
7/6/2023Q1 2023--$0.80 -$0.80-$0.17-$14.83M
3/23/2023Q4 2022-$0.30-$0.90 -$0.60-$0.10$18.00M$18.04M
12/15/2022Q3 2022-$0.20-$0.90 -$0.70-$0.12$19.50M$19.50M

Trinity Biotech Earnings - Frequently Asked Questions

Trinity Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based off last year's report dates. Learn more on TRIB's earnings history.

In the previous quarter, Trinity Biotech (NASDAQ:TRIB) reported ($0.55) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.65) by $0.10. Learn more on analysts' earnings estimate vs. TRIB's actual earnings.

Trinity Biotech (NASDAQ:TRIB) has a recorded annual revenue of $58.65 million.

Trinity Biotech (NASDAQ:TRIB) has a recorded net income of -$24.02 million. TRIB has generated -$2.70 earnings per share over the last four quarters.

Trinity Biotech's earnings are expected to grow from ($1.91) per share to ($1.03) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:TRIB) was last updated on 11/12/2024 by MarketBeat.com Staff
From Our Partners